Cargando…
Using artificial intelligence for diabetic retinopathy screening: Policy implications
Artificial intelligence (AI) has evolved over the last few years; its use in DR screening has been demonstrated in multiple evidences across the globe. However, there are concerns right from the data acquisition, bias in data, difficulty in comparing between different algorithm, challenges in machin...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725146/ https://www.ncbi.nlm.nih.gov/pubmed/34708734 http://dx.doi.org/10.4103/ijo.IJO_1420_21 |